A detailed history of Sterling Financial Planning, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Sterling Financial Planning, Inc. holds 863 shares of LLY stock, worth $775,060. This represents 0.28% of its overall portfolio holdings.

Number of Shares
863
Previous 857 0.7%
Holding current value
$775,060
Previous $499,000 34.47%
% of portfolio
0.28%
Previous 0.22%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$592.2 - $792.28 $3,553 - $4,753
6 Added 0.7%
863 $671,000
Q4 2023

Jan 31, 2024

BUY
$525.19 - $619.13 $10,503 - $12,382
20 Added 2.39%
857 $499,000
Q4 2022

Feb 06, 2023

SELL
$321.55 - $374.67 $4,501 - $5,245
-14 Reduced 1.65%
837 $306,000
Q3 2021

Oct 28, 2021

SELL
$221.6 - $272.71 $21,052 - $25,907
-95 Reduced 10.04%
851 $197,000
Q4 2020

Feb 10, 2021

BUY
$130.46 - $172.63 $123,415 - $163,307
946 New
946 $160,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $853B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sterling Financial Planning, Inc. Portfolio

Follow Sterling Financial Planning, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Financial Planning, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sterling Financial Planning, Inc. with notifications on news.